Dysfunction of the Na current (INa) flowing through the ? subunit of the cardiac Na channel encoded by SCN5A participates in pathogenic mechanisms for arrhythmia, heart failure, and ischemia. Over the past 9 years we have been an active participant and contributor as the field progressed from discovery of arrhythmia mutations in ? subunits of ion channels to discovery of mutations in other subunits and associated proteins that form ion channel macromolecular complexes (MMCs). The MMC for INa now has at least 21 associated components that we will call MMCCs. These include subunits, ChIPs, scaffolding, and adapter and regulatory proteins. In the past 4-year period we identified ten new clinical syndromes involving """"""""arrhythmia genes"""""""" encoding INa- MMCCs: CAV3 in LQT9 and SIDS, SCN4B in LQT10 and SIDS, SNTA1 in LQT12 and SIDS, GPD1L in SIDS, and SCNB3 in IVF and SIDS;all of these we showed to cause dysfunction of INa. We also made progress on mechanism showing that GPD1L mutations decrease INa through a mechanism of direct SCN5A phosphorylation and that SNTA1 mutations increase late INa through a mechanism of direct nitrosylation of SCN5A. In the next project period we propose to more thoroughly investigate mechanisms of CAV3 and SNTA1 action on INa involving nitrosylation of SCN5A and the MMCC Nedd4.2L.
In Aim 1 we will elucidate mechanisms for INa dysfunction (gain of function or late INa) involving direct nitrosylation of SCN5A.
In Aim 2 we will elucidate mechanisms for INa dysfunction (loss of function or INa) involving nitrosylation of Nedd4.2L.
In Aim 3 we will determine compositions and locations of different types of INa-MMCs in mouse and human heart with a focus on CAV3-MMCCs. And we will continue the gene discovery efforts under Aim 4 where we will characterize INa from novel mutations in INa-MMCCs identified in screens of arrhythmia patients who are not linked to known genotypes and determine the mechanism of action that affect INa. We already have two novel candidate genes with two mutations in SAP97 and three mutations in Nedd4.2L from patients with Brugada syndrome. The progress on this project on arrhythmia gene discovery will have impact on increasing the diagnostic yield for patients with inherited arrhythmias. The elucidation of mechanisms by which these gene products affect INa will produce insights into both physiological regulation of INa, and pathophysiological causes of INa dysfunction for both inherited arrhythmia and commonly acquired cardiac diseases such as heart failure and ischemia.

Public Health Relevance

This project will investigate how recently discovered inherited arrhythmia mutation genes affect sodium current to cause the arrhythmia. This may lead to improvements in therapy. Moreover, it aims to discover new arrhythmia genes and thus help more families with inherited arrhythmia by giving them a more specific diagnosis and an approach to improved therapy.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Wang, Lan-Hsiang
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Cheng, Jianding; Kyle, John W; Wiedmeyer, Brandi et al. (2017) Vinculin variant M94I identified in sudden unexplained nocturnal death syndrome decreases cardiac sodium current. Sci Rep 7:42953
Huang, Lei; Tang, Shuangbo; Chen, Yili et al. (2017) Molecular pathological study on LRRC10 in sudden unexplained nocturnal death syndrome in the Chinese Han population. Int J Legal Med 131:621-628
Makielski, Jonathan C (2016) Late sodium current: A mechanism for angina, heart failure, and arrhythmia. Trends Cardiovasc Med 26:115-22
Zhao, Qianhao; Chen, Yili; Peng, Longlun et al. (2016) Identification of rare variants of DSP gene in sudden unexplained nocturnal death syndrome in the southern Chinese Han population. Int J Legal Med 130:317-22
Zhang, Liyong; Tester, David J; Lang, Di et al. (2016) Does Sudden Unexplained Nocturnal Death Syndrome Remain the Autopsy-Negative Disorder: A Gross, Microscopic, and Molecular Autopsy Investigation in Southern China. Mayo Clin Proc 91:1503-1514
Zheng, Jinxiang; Zhou, Feng; Su, Terry et al. (2016) The biophysical characterization of the first SCN5A mutation R1512W identified in Chinese sudden unexplained nocturnal death syndrome. Medicine (Baltimore) 95:e3836
Hu, Rou-Mu; Tan, Bi-Hua; Tester, David J et al. (2015) Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis. PLoS One 10:e0124921
Makielski, Jonathan C; Kyle, John W (2015) Late I(Na) in the Heart: Physiology, Pathology, and Pathways. Circulation 132:553-5
Adsit, Graham S; Vaidyanathan, Ravi; Galler, Carla M et al. (2013) Channelopathies from mutations in the cardiac sodium channel protein complex. J Mol Cell Cardiol 61:34-43
Cheng, Jianding; Valdivia, Carmen R; Vaidyanathan, Ravi et al. (2013) Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A. J Mol Cell Cardiol 61:102-10

Showing the most recent 10 out of 16 publications